171 related articles for article (PubMed ID: 38687678)
1. Loss of tumor suppressor TMEM127 drives RET-mediated transformation through disrupted membrane dynamics.
Walker TJ; Reyes-Alvarez E; Hyndman BD; Sugiyama MG; Oliveira LCB; Rekab AN; Crupi MJF; Cabral-Dias R; Guo Q; Dahia PLM; Richardson DS; Antonescu CN; Mulligan LM
Elife; 2024 Apr; 12():. PubMed ID: 38687678
[TBL] [Abstract][Full Text] [Related]
2. Loss of Tumour Suppressor TMEM127 Drives RET-mediated Transformation Through Disrupted Membrane Dynamics.
Walker TJ; Reyes-Alvarez E; Hyndman BD; Sugiyama MG; Oliveira LCB; Rekab AN; Crupi MJF; Cabral-Dias R; Guo Q; Dahia PLM; Richardson DS; Antonescu CN; Mulligan LM
bioRxiv; 2024 Apr; ():. PubMed ID: 37425958
[TBL] [Abstract][Full Text] [Related]
3. TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradation.
Guo Q; Cheng ZM; Gonzalez-Cantú H; Rotondi M; Huelgas-Morales G; Ethiraj P; Qiu Z; Lefkowitz J; Song W; Landry BN; Lopez H; Estrada-Zuniga CM; Goyal S; Khan MA; Walker TJ; Wang E; Li F; Ding Y; Mulligan LM; Aguiar RCT; Dahia PLM
Cell Rep; 2023 Sep; 42(9):113070. PubMed ID: 37659079
[TBL] [Abstract][Full Text] [Related]
4. Functional Characterization of TMEM127 Variants Reveals Novel Insights into Its Membrane Topology and Trafficking.
Flores SK; Deng Y; Cheng Z; Zhang X; Tao S; Saliba A; Chu I; Burnichon N; Gimenez-Roqueplo AP; Wang E; Aguiar RCT; Dahia PLM
J Clin Endocrinol Metab; 2020 Sep; 105(9):e3142-56. PubMed ID: 32575117
[TBL] [Abstract][Full Text] [Related]
5. The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo.
Oliveira MN; Hemerly JP; Bastos AU; Tamanaha R; Latini FR; Camacho CP; Impellizzeri A; Maciel RM; Cerutti JM
Thyroid; 2011 Sep; 21(9):975-85. PubMed ID: 21834681
[TBL] [Abstract][Full Text] [Related]
6. The TMEM127 human tumor suppressor is a component of the mTORC1 lysosomal nutrient-sensing complex.
Deng Y; Qin Y; Srikantan S; Luo A; Cheng ZM; Flores SK; Vogel KS; Wang E; Dahia PLM
Hum Mol Genet; 2018 May; 27(10):1794-1808. PubMed ID: 29547888
[TBL] [Abstract][Full Text] [Related]
7. RET ligand-induced internalization and its consequences for downstream signaling.
Richardson DS; Lai AZ; Mulligan LM
Oncogene; 2006 May; 25(22):3206-11. PubMed ID: 16418724
[TBL] [Abstract][Full Text] [Related]
8. ErbB-2 induces bilateral adrenal pheochromocytoma formation in mice.
Lai EW; Rodriguez OC; Aventian M; Cromelin C; Fricke ST; Martiniova L; Lubensky IA; Lisanti MP; Picard KL; Powers JF; Tischler AS; Pacak K; Albanese C
Cell Cycle; 2007 Aug; 6(15):1946-50. PubMed ID: 17671425
[TBL] [Abstract][Full Text] [Related]
9. Distinct Temporal Regulation of RET Isoform Internalization: Roles of Clathrin and AP2.
Crupi MJ; Yoganathan P; Bone LN; Lian E; Fetz A; Antonescu CN; Mulligan LM
Traffic; 2015 Nov; 16(11):1155-73. PubMed ID: 26304132
[TBL] [Abstract][Full Text] [Related]
10. Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas.
Yao L; Schiavi F; Cascon A; Qin Y; Inglada-Pérez L; King EE; Toledo RA; Ercolino T; Rapizzi E; Ricketts CJ; Mori L; Giacchè M; Mendola A; Taschin E; Boaretto F; Loli P; Iacobone M; Rossi GP; Biondi B; Lima-Junior JV; Kater CE; Bex M; Vikkula M; Grossman AB; Gruber SB; Barontini M; Persu A; Castellano M; Toledo SP; Maher ER; Mannelli M; Opocher G; Robledo M; Dahia PL
JAMA; 2010 Dec; 304(23):2611-9. PubMed ID: 21156949
[TBL] [Abstract][Full Text] [Related]
11. A novel TMEM127 mutation in a patient with familial bilateral pheochromocytoma.
Burnichon N; Lepoutre-Lussey C; Laffaire J; Gadessaud N; Molinié V; Hernigou A; Plouin PF; Jeunemaitre X; Favier J; Gimenez-Roqueplo AP
Eur J Endocrinol; 2011 Jan; 164(1):141-5. PubMed ID: 20923864
[TBL] [Abstract][Full Text] [Related]
12. Homozygous TMEM127 mutations in 2 patients with bilateral pheochromocytomas.
Eijkelenkamp K; Olderode-Berends MJW; van der Luijt RB; Robledo M; van Dooren M; Feelders RA; de Vries J; Kerstens MN; Links TP; van der Horst-Schrivers ANA
Clin Genet; 2018 May; 93(5):1049-1056. PubMed ID: 29282712
[TBL] [Abstract][Full Text] [Related]
13. GIPC2 is an endocrine-specific tumor suppressor gene for both sporadic and hereditary tumors of RET- and SDHB-, but not VHL-associated clusters of pheochromocytoma/paraganglioma.
Dong Y; Huang Y; Fan C; Wang L; Zhang R; Li W; Guo Z; Wang D; Zheng Z
Cell Death Dis; 2021 May; 12(5):444. PubMed ID: 33947839
[TBL] [Abstract][Full Text] [Related]
14. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma.
Qin Y; Yao L; King EE; Buddavarapu K; Lenci RE; Chocron ES; Lechleiter JD; Sass M; Aronin N; Schiavi F; Boaretto F; Opocher G; Toledo RA; Toledo SP; Stiles C; Aguiar RC; Dahia PL
Nat Genet; 2010 Mar; 42(3):229-33. PubMed ID: 20154675
[TBL] [Abstract][Full Text] [Related]
15. RET expression and neuron-like differentiation of pheochromocytoma and normal chromaffin cells.
Powers JF; Picard KL; Tischler AS
Horm Metab Res; 2009 Sep; 41(9):710-4. PubMed ID: 19551609
[TBL] [Abstract][Full Text] [Related]
16. TMEM127 screening in a large cohort of patients with pheochromocytoma and/or paraganglioma.
Abermil N; Guillaud-Bataille M; Burnichon N; Venisse A; Manivet P; Guignat L; Drui D; Chupin M; Josseaume C; Affres H; Plouin PF; Bertherat J; Jeunemaître X; Gimenez-Roqueplo AP
J Clin Endocrinol Metab; 2012 May; 97(5):E805-9. PubMed ID: 22419703
[TBL] [Abstract][Full Text] [Related]
17. RET/PTC1-driven neoplastic transformation and proinvasive phenotype of human thyrocytes involve Met induction and beta-catenin nuclear translocation.
Cassinelli G; Favini E; Degl'Innocenti D; Salvi A; De Petro G; Pierotti MA; Zunino F; Borrello MG; Lanzi C
Neoplasia; 2009 Jan; 11(1):10-21. PubMed ID: 19107227
[TBL] [Abstract][Full Text] [Related]
18. Differential membrane compartmentalization of Ret by PTB-adaptor engagement.
Lundgren TK; Luebke M; Stenqvist A; Ernfors P
FEBS J; 2008 May; 275(9):2055-66. PubMed ID: 18355321
[TBL] [Abstract][Full Text] [Related]
19. GGA3-mediated recycling of the RET receptor tyrosine kinase contributes to cell migration and invasion.
Crupi MJF; Maritan SM; Reyes-Alvarez E; Lian EY; Hyndman BD; Rekab AN; Moodley S; Antonescu CN; Mulligan LM
Oncogene; 2020 Feb; 39(6):1361-1377. PubMed ID: 31645646
[TBL] [Abstract][Full Text] [Related]
20. Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells.
Hennige AM; Lammers R; Arlt D; Höppner W; Strack V; Niederfellner G; Seif FJ; Häring HU; Kellerer M
Mol Cell Endocrinol; 2000 Sep; 167(1-2):69-76. PubMed ID: 11000521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
